Total medical devices industry M&A deals worth $2.41bn were announced in North America in March 2021, led by Agilent Technologies’ $695m acquisition of Resolution Bioscience, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 1.3% over the previous month of $2.38bn and a drop of 66.1% when compared with the last 12-month average of $7.11bn.
North America held a 62.44% share of the global medical devices industry M&A deal value that totalled $3.86bn in March 2021. With a 57.77% share and deals worth $2.23bn, the US was the top country in North America’s M&A deal value across medical devices industry.
In terms of M&A deal activity, North America recorded 26 deals during March 2021, marking a decrease of 21.21% over the previous month and a rise of 8.33% over the 12-month average. The US recorded 23 deals during the month.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataNorth America medical devices industry M&A deals in March 2021: Top deals
The top five medical devices industry M&A deals accounted for 79.7% of the overall value during March 2021.
The combined value of the top five medical devices deals stood at $1.92bn, against the overall value of $2.41bn recorded for the month.
The top five medical devices industry M&A deals of March 2021 tracked by GlobalData were:
1) Agilent Technologies’ $695m acquisition of Resolution Bioscience
2) The $475m acquisition of Northfield Medical by Agiliti
3) Bio Techne’s $320m acquisition of Asuragen
4) The $240m acquisition of Alydia Health by Organon &
5) Specialists On Call’s acquisition of Access Physicians for $194m.
